TABLE 2.

Distribution of patients who did or did not experience a ≥4-fold decline in anti-C6 antibody GMT at ≥6 months after diagnosis

Disease stageC6 GMT ≥4-fold lower than at baseline (no. of patients)Total
YesNo
EM11011
Disseminated25934
    Total36945